Cite
HARVARD Citation
Fan, X. et al. (2022). Suppression of the transforming growth factor-β signaling pathway produces a synergistic effect of combination therapy with programmed death receptor 1 blockade and radiofrequency ablation against hepatic carcinoma in mice. Bioengineered. 13 (4), pp. 9046-9058. [Online].